se ha leído el artículo
array:19 [ "pii" => "X0211699500025846" "issn" => "02116995" "estado" => "S300" "fechaPublicacion" => "2000-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2000;20 Supl 1:18" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1586 "formatos" => array:3 [ "EPUB" => 164 "HTML" => 1160 "PDF" => 262 ] ] "itemSiguiente" => array:15 [ "pii" => "X0211699500025838" "issn" => "02116995" "estado" => "S300" "fechaPublicacion" => "2000-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2000;20 Supl 1:19" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3500 "formatos" => array:3 [ "EPUB" => 168 "HTML" => 2829 "PDF" => 503 ] ] "es" => array:8 [ "idiomaDefecto" => true "titulo" => "«EL RIÑÓN EN LA HIPERTENSIÓN ESENCIAL» Papel del riñón en la patogénesis de la hipertensión arterial" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "19" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "L. M. RUILOPE" "autores" => array:1 [ 0 => array:1 [ "nombre" => "L. M. RUILOPE" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025838?idApp=UINPBA000064" "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025838/v0_201502091333/es/main.assets" ] "itemAnterior" => array:15 [ "pii" => "X0211699500025854" "issn" => "02116995" "estado" => "S300" "fechaPublicacion" => "2000-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2000;20 Supl 1:16-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2256 "formatos" => array:3 [ "EPUB" => 162 "HTML" => 1700 "PDF" => 394 ] ] "es" => array:8 [ "idiomaDefecto" => true "titulo" => "Papel del TGF- ?1 en la progresión de la Nefropatía Crónica del Injerto renal. Efecto del Bloqueo de la Angiotensina II" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "16" "paginaFinal" => "17" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. M. CAMPISTOL" "autores" => array:1 [ 0 => array:1 [ "nombre" => "J. M. CAMPISTOL" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025854?idApp=UINPBA000064" "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025854/v0_201502091333/es/main.assets" ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Transcriptional regulation of the human INOS gene by IL-1 ? in endothelial cells" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "18" ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "N. E. MADIAS" "autores" => array:1 [ 0 => array:1 [ "nombre" => "N. E. MADIAS" ] ] ] ] "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 Transcriptional regulation of the human INOS gene by IL-1 in endothelial cells N. E. Madias Department of Medicine, Tufts University School of Medicine, and the Division of Nephrology and the Tupper Research Institute, New England Medical Center, Boston, Massachusetts, USA. The inducible isoform of the nitric oxide synthase (iNOS) is expressed in many tissues, including the vascular endothelium, after induction by various inflammatory stimuli. In view of the direct contact of endothelial cells with circulating blood, production of large amounts of nitric oxide by endothelial iNOS might occur under various clinical conditions characterized by entry of microorganisms and their products into the blood stream or a surge of cytokines, including sepsis, dialysis, cytokine therapy, graft rejection, or regional inflammation. A host of pathophysiologic effects might emanate from the resultant release of nitric oxide, such as profound vasodilation and hypotension, aggravation of inflammation, cytotoxicity, antimicrobial defense, and inhibition of adhesion and aggregation of leukocytes and platelets. The bulk of the work on the transcriptional regulation of the iNOS gene has involved the murine gene in macrophages and vascular smooth muscle (VSM) cells. Corresponding work in the rat iNOS gene has largely focused on macrophages, VSM cells, and mesangial cells. There is currently no information on the transcriptional regulation of the human iNOS gene (or that of other species) in endothelial cells. Previously, we demonstrated that a 1.1-kb human iNOS promoter/luciferase construct was induced strongly by LPS and only modestly by IL-1 in macrophages, but not in VSM cells. In this study, we examined the transcriptional regulation of IL-1-induced expression of the human iNOS gene in rat pulmonary vein endothelial cells (PVEC). Transfection experiments demonstrated that this human iNOS promoter was strongly inducible by IL-1 (6fold on average) in PVEC. Mutational analysis suggested that the putative cis-regulatory elements responsible for this induction are localized within the -205/+88 bp promoter fragment. Further mutational analysis and cotransfection experiments with expression vectors for different isoforms of NF-B, IB, and Ib kinase (IKK) suggested that the NF-B site located within this region (at position -115 to -106 bp) is important, but not sufficient, for full induction of the human iNOS promoter by IL-1. We then identified four C/EBP binding sites within the -205/+88 bp region. Mutational analysis demonstrated that these C/EBP sites along with the NF-B site are largely responsible for the induction of the human iNOS promoter by IL-1. Overexpression of C/EBP isoforms revealed that C/EBP sites participate in the induction of the human iNOS promoter by IL1. Cotransfection with expression vector for liverenriched transcriptional activator protein (LAP) activated the human iNOS promoter to the same level as IL-1 treatment, whereas expression vector for liver-enriched transcriptional inhibitory protein (LIP) resulted in strong downregulation of basal and IL1-induced promoter activity. Western blot analysis showed that C/EBP (LAP and LIP isoforms) was constitutively present in PVEC and was induced (~2fold) by IL-1. On the other hand, C/EBP was not constitutively expressed but was strongly induced by IL-1. No other C/EBP isoforms were detectable. However, EMSA analysis demonstrated that in untreated cells C/EBP, although present by Western blot, did not bind to DNA. Supershift assays showed that in IL-1-treated cells both C/EBP and C/EBP, but not C/EBP or C/EBP, participated in complex formation. We conclude that the cis-regulatory elements responsible for the transcriptional activation of the human iNOS gene by IL-1 in endothelial cells are localized in the 5'-flanking region downstream of -0,2 kb. Further, our data demonstrate that such induction depends on transcription factors NF-B, C/EBP, and C/EBP. These data provide new insight into the themes of complexity and tissue specificity that characterize the transcriptional regulation of the human iNOS gene. 18 " "pdfFichero" => "P7-E170-S140-A1870.pdf" "tienePdf" => true ] "idiomaDefecto" => "en" "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025846/v0_201502091333/en/main.assets" "Apartado" => array:4 [ "identificador" => "35407" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Suplementos" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025846/v0_201502091333/en/P7-E170-S140-A1870.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025846?idApp=UINPBA000064" ]
Idioma original: Inglés
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 7 | 11 | 18 |
2024 Octubre | 41 | 37 | 78 |
2024 Septiembre | 44 | 22 | 66 |
2024 Agosto | 55 | 57 | 112 |
2024 Julio | 44 | 36 | 80 |
2024 Junio | 47 | 38 | 85 |
2024 Mayo | 55 | 37 | 92 |
2024 Abril | 41 | 27 | 68 |
2024 Marzo | 31 | 22 | 53 |
2024 Febrero | 34 | 50 | 84 |
2024 Enero | 17 | 27 | 44 |
2023 Diciembre | 20 | 19 | 39 |
2023 Noviembre | 38 | 31 | 69 |
2023 Octubre | 29 | 23 | 52 |
2023 Septiembre | 51 | 18 | 69 |
2023 Agosto | 32 | 20 | 52 |
2023 Julio | 39 | 26 | 65 |
2023 Junio | 28 | 17 | 45 |
2023 Mayo | 39 | 26 | 65 |
2023 Abril | 40 | 15 | 55 |
2023 Marzo | 34 | 23 | 57 |
2023 Febrero | 32 | 25 | 57 |
2023 Enero | 31 | 17 | 48 |
2022 Diciembre | 33 | 32 | 65 |
2022 Noviembre | 32 | 22 | 54 |
2022 Octubre | 39 | 45 | 84 |
2022 Septiembre | 37 | 25 | 62 |
2022 Agosto | 28 | 39 | 67 |
2022 Julio | 47 | 39 | 86 |
2022 Junio | 38 | 22 | 60 |
2022 Mayo | 42 | 29 | 71 |
2022 Abril | 45 | 35 | 80 |
2022 Marzo | 32 | 33 | 65 |
2022 Febrero | 29 | 33 | 62 |
2022 Enero | 33 | 20 | 53 |
2021 Diciembre | 20 | 38 | 58 |
2021 Noviembre | 23 | 22 | 45 |
2021 Octubre | 29 | 35 | 64 |
2021 Septiembre | 16 | 27 | 43 |
2021 Agosto | 25 | 35 | 60 |
2021 Julio | 20 | 25 | 45 |
2021 Junio | 13 | 29 | 42 |
2021 Mayo | 32 | 21 | 53 |
2021 Abril | 20 | 59 | 79 |
2021 Marzo | 34 | 17 | 51 |
2021 Febrero | 53 | 17 | 70 |
2021 Enero | 15 | 6 | 21 |
2020 Diciembre | 15 | 14 | 29 |
2020 Noviembre | 16 | 2 | 18 |
2020 Octubre | 11 | 8 | 19 |
2020 Septiembre | 16 | 6 | 22 |
2020 Agosto | 22 | 7 | 29 |
2020 Julio | 17 | 6 | 23 |
2020 Junio | 15 | 9 | 24 |
2020 Mayo | 26 | 10 | 36 |
2020 Abril | 41 | 8 | 49 |
2020 Marzo | 27 | 14 | 41 |
2020 Febrero | 25 | 11 | 36 |
2020 Enero | 26 | 9 | 35 |
2019 Diciembre | 12 | 8 | 20 |
2019 Noviembre | 7 | 4 | 11 |
2019 Octubre | 14 | 6 | 20 |
2019 Septiembre | 10 | 14 | 24 |
2019 Agosto | 7 | 8 | 15 |
2019 Julio | 13 | 10 | 23 |
2019 Junio | 19 | 4 | 23 |
2019 Mayo | 13 | 7 | 20 |
2019 Abril | 39 | 29 | 68 |
2019 Marzo | 13 | 8 | 21 |
2019 Febrero | 7 | 13 | 20 |
2019 Enero | 9 | 7 | 16 |
2018 Diciembre | 26 | 21 | 47 |
2018 Noviembre | 19 | 6 | 25 |
2018 Octubre | 21 | 6 | 27 |
2018 Septiembre | 15 | 5 | 20 |
2018 Agosto | 16 | 6 | 22 |
2018 Julio | 13 | 5 | 18 |
2018 Junio | 10 | 9 | 19 |
2018 Mayo | 17 | 4 | 21 |
2018 Abril | 13 | 9 | 22 |
2018 Marzo | 17 | 3 | 20 |
2018 Febrero | 21 | 5 | 26 |
2018 Enero | 5 | 4 | 9 |
2017 Diciembre | 22 | 5 | 27 |
2017 Noviembre | 11 | 5 | 16 |
2017 Octubre | 10 | 3 | 13 |
2017 Septiembre | 9 | 3 | 12 |
2017 Agosto | 19 | 7 | 26 |
2017 Julio | 9 | 2 | 11 |
2017 Junio | 16 | 3 | 19 |
2017 Mayo | 10 | 0 | 10 |
2017 Abril | 12 | 1 | 13 |
2017 Marzo | 6 | 1 | 7 |
2017 Febrero | 9 | 2 | 11 |
2017 Enero | 5 | 2 | 7 |
2016 Diciembre | 19 | 2 | 21 |
2016 Noviembre | 23 | 1 | 24 |
2016 Octubre | 40 | 5 | 45 |
2016 Septiembre | 32 | 0 | 32 |
2016 Agosto | 56 | 2 | 58 |
2016 Julio | 58 | 3 | 61 |
2016 Junio | 86 | 0 | 86 |
2016 Mayo | 60 | 0 | 60 |
2016 Abril | 18 | 0 | 18 |
2016 Marzo | 26 | 0 | 26 |
2016 Febrero | 11 | 0 | 11 |
2016 Enero | 15 | 0 | 15 |
2015 Diciembre | 43 | 0 | 43 |
2015 Noviembre | 22 | 0 | 22 |
2015 Octubre | 24 | 0 | 24 |
2015 Septiembre | 27 | 0 | 27 |
2015 Agosto | 22 | 0 | 22 |
2015 Julio | 16 | 0 | 16 |
2015 Junio | 16 | 0 | 16 |
2015 Mayo | 15 | 0 | 15 |